Corbus Pharmaceuticals Holdings annual revenue
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Corbus Pharmaceuticals Holdings Revenue Growth & History (CRBP)
Corbus Pharmaceuticals Holdings reported $0 in revenue for fiscal 2025.
View full Corbus Pharmaceuticals Holdings company overviewCorbus Pharmaceuticals Holdings annual revenue and growth
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $0 | $0 | — |
| 2024 | 2024-12-31 | $0 | $0 | — |
| 2023 | 2023-12-31 | $0 | $0 | — |
| 2022 | 2022-12-31 | $0 | −$881,705 | −100.00% |
| 2021 | 2021-12-31 | $881,705 | −$3.1M | −77.61% |
| 2020 | 2020-12-31 | $3.9M | −$32.2M | −89.11% |
| 2019 | 2019-12-31 | $36.1M | $31.3M | +649.51% |
| 2018 | 2018-12-31 | $4.8M | $2.4M | +97.62% |
| 2017 | 2017-12-31 | $2.4M | $528,771 | +27.66% |
| 2016 | 2016-12-31 | $1.9M | $1.3M | +194.80% |
| 2015 | 2015-12-31 | $648,382 | — | — |
Corbus Pharmaceuticals Holdings quarterly revenue
Q3.14
Q1.15
Q2.15
Q3.15
Q4.15
Q1.16
Q2.16
Q3.16
Q4.16
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q3.22
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Revenue | Change | YoY growth |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $0 | $0 | — |
| Q1 2026 | 2026-03-31 | $0 | — | — |
| Q4 2025 | 2025-12-31 | $0 | — | — |
| Q3 2025 | 2025-09-30 | $0 | — | — |
| Q2 2025 | 2025-06-30 | $0 | — | — |
| Q3 2022 | 2022-09-30 | $0 | −$97,323 | −100.00% |
| Q1 2022 | 2022-03-31 | $0 | −$647,824 | −100.00% |
| Q4 2021 | 2021-12-31 | $0 | −$658,204 | −100.00% |
| Q3 2021 | 2021-09-30 | $97,323 | −$1.1M | −92.09% |
| Q2 2021 | 2021-06-30 | $136,558 | −$149,788 | −52.31% |
| Q1 2021 | 2021-03-31 | $647,824 | −$1.1M | −63.23% |
| Q4 2020 | 2020-12-31 | $658,204 | −$1.9M | −74.42% |
| Q3 2020 | 2020-09-30 | $1.2M | −$1.4M | −52.48% |
| Q2 2020 | 2020-06-30 | $286,346 | −$28.8M | −99.02% |
| Q1 2020 | 2020-03-31 | $1.8M | −$123,623 | −6.56% |
| Q4 2019 | 2019-12-31 | $2.6M | $646,214 | +33.53% |
| Q3 2019 | 2019-09-30 | $2.6M | $1.5M | +137.40% |
| Q2 2019 | 2019-06-30 | $29.1M | $28.2M | +3308.27% |
| Q1 2019 | 2019-03-31 | $1.9M | $935,240 | +98.40% |
| Q4 2018 | 2018-12-31 | $1.9M | $1.9M | — |
| Q3 2018 | 2018-09-30 | $1.1M | $294,566 | +36.99% |
| Q2 2018 | 2018-06-30 | $853,646 | $503,460 | +143.77% |
| Q1 2018 | 2018-03-31 | $950,442 | −$343,255 | −26.53% |
| Q4 2017 | 2017-12-31 | $0 | −$375,670 | −100.00% |
| Q3 2017 | 2017-09-30 | $796,312 | $53,754 | +7.24% |
| Q2 2017 | 2017-06-30 | $350,186 | −$46,412 | −11.70% |
| Q1 2017 | 2017-03-31 | $1.3M | $897,099 | +226.20% |
| Q4 2016 | 2016-12-31 | $375,670 | $11,378 | +3.12% |
| Q3 2016 | 2016-09-30 | $742,558 | $572,104 | +335.64% |
| Q2 2016 | 2016-06-30 | $396,598 | $282,962 | +249.01% |
| Q1 2016 | 2016-03-31 | $396,598 | $396,598 | — |
| Q4 2015 | 2015-12-31 | $364,292 | — | — |
| Q3 2015 | 2015-09-30 | $170,454 | $170,454 | — |
| Q2 2015 | 2015-06-30 | $113,636 | — | — |
| Q1 2015 | 2015-03-31 | $0 | — | — |
| Q3 2014 | 2014-09-30 | $0 | — | — |
Corbus Pharmaceuticals Holdings revenue growth trends
Corbus Pharmaceuticals Holdings's latest reported quarter, Q2 2026, generated $0 in revenue.
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Financial data
Standardized company financials
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review Corbus Pharmaceuticals Holdings source filings ↗